Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B.

Neurology - 15 Jan 1999

Kastrukoff L F, Morgan N G, Zecchini D, White R, Petkau A J, Satoh J, Paty D W

Abstract excerpt

OBJECTIVE: To determine the effect of treatment with interferon beta-1b (IFN-beta) on natural killer (NK) cell function and phenotype in relapsing-remitting MS (RRMS) patients, and their relationship to disease activity assessed both clinically and with serial MRI. BACKGROUND: NK cells may play a role in the immunopathogenesis of MS. Previously the authors reported a positive relationship between mean NK cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Double-Blind Method
Share to Flow Cytometry
Share to Killer Cells, Natural

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Magnetic Resonance Imaging

Share to Multiple Sclerosis

Share to Phenotype

Share to Recombinant Proteins

Share to Recurrence

Source

Identifiers

PMID: 9932956
DOI: 10.1212/wnl.52.2.351

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B.PMID 9932956Read ↗

IFNβ-1b treatment leads to changes in the B cell subset and cytokine secretion profile in patients with relapsing-remitting multiple sclerosisSemantic proximity Read ↗

Regulatory Functions of Natural Killer Cells in Multiple SclerosisSemantic proximity Read ↗

Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometrySemantic proximity Read ↗

Cladribine: mechanisms and mysteries in multiple sclerosisSemantic proximity Read ↗

Immune surveillance in multiple sclerosis patients treated with natalizumab.Semantic proximity Read ↗

Natural killer type 2 bias in remission of multiple sclerosis.Semantic proximity Read ↗

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis.Semantic proximity Read ↗

HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.Semantic proximity Read ↗

Natalizumab effects on immune cell responses in multiple sclerosis.Semantic proximity Read ↗

Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis.Semantic proximity Read ↗

NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.